Tela Bio appoints Jeffrey Blizard to its board of directors

TELA Bio (TELA) announced that it has appointed Jeffrey Blizard, the Global Head of Surgical Sales for Abiomed (ABMD), a medical device technology company that operates as a stand-alone business within Johnson & Johnson’s (JNJ)MedTech Segment, to its Board of Directors, effective June 4. “We are excited to have Jeff join our Board as we continue to develop and optimize our sales force,” said Antony Koblish, co-founder, President and Chief Executive Officer of TELA Bio. “Jeff’s exceptional sales leadership and extensive experience will be a tremendous asset to our Board of Directors.” “I am thrilled to join TELA Bio’s Board of Directors during this dynamic period of growth,” said Mr. Blizard. “I am confident that my broad range of sales expertise will significantly contribute to the TELA’s continued success.”